Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Current Assets (2010 - 2026)

Creative Medical Technology Holdings' (CELZ) quarterly Current Assets came in at $9.0 million in Q2 2026, up 35.98% year-over-year from $6.6 million in Q2 2025, and up 48.85% quarter-over-quarter from $6.1 million in Q1 2026.

Analysis

Creative Medical Technology Holdings (CELZ) Current Assets (2010 - 2026) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Current Assets for 17 consecutive years, with $9.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Assets rose 35.98% year-over-year to $9.0 million in Q2 2026; TTM through Jun 2026 was $9.0 million, a 35.98% increase from a year earlier, with the FY2025 full-year figure at $7.4 million, up 20.6% from the prior year.
  • Current Assets was $9.0 million for Q2 2026 at Creative Medical Technology Holdings, up from $6.1 million in the prior quarter.
  • Over five years, Current Assets peaked at $22.9 million in Q2 2022 and troughed at $5.4 million in Q3 2025.
  • A 5-year average of $10.9 million and a median of $9.1 million in 2024 frame the typical range for Current Assets.
  • Across the five-year window, Current Assets soared 14370.99% in 2022 and tumbled 47.43% in 2024, its largest moves.
  • Over 5 years, Current Assets stood at $18.7 million in 2022, then sank by 45.21% to $10.3 million in 2023, then slumped by 40.27% to $6.1 million in 2024, then grew by 20.6% to $7.4 million in 2025, then rose by 21.89% to $9.0 million in 2026.
  • The last three Current Assets figures came in at $9.0 million (Q2 2026), $6.1 million (Q1 2026), and $7.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 1.06 Bn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - 2.37 Bn
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn 464.26 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 1.23 Bn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn 834.27 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn - 1.18 Bn
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 134.38 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn 2.22 Bn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 264.73 Mn
10 Creative Medical Technology Holdings 1.48 Mn 1.50 Mn - 9.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.02 Mn
Mar 31, 2026 6.06 Mn
Dec 31, 2025 7.40 Mn
Sep 30, 2025 5.41 Mn
Jun 30, 2025 6.63 Mn
Mar 31, 2025 7.84 Mn
Dec 31, 2024 6.14 Mn
Sep 30, 2024 6.33 Mn
Jun 30, 2024 7.60 Mn
Mar 31, 2024 9.20 Mn
Dec 31, 2023 10.27 Mn
Sep 30, 2023 12.04 Mn
Jun 30, 2023 13.73 Mn
Mar 31, 2023 14.81 Mn
Dec 31, 2022 18.75 Mn
Sep 30, 2022 22.01 Mn
Jun 30, 2022 22.95 Mn
Mar 31, 2022 9.23 Mn
Dec 31, 2021 10.74 Mn
Sep 30, 2021 2.58 Mn